Philip Morris International Inc. PM

NYSE · Consumer Defensive · Tobacco

$184.09

Close on Fri, 20 Nov 2026 · market value $287B

What the price is betting on

Below its record

At $184, the price assumes revenue grows about 0.2% a year for five years, from $43.1B to about $43.5B by FY2030. That is less than what analysts expect for the next two years and less than the company's own last three years.

The price assumes0.2%
Analysts, next two years5.4%
Last 3 years7.7%

Revenue growth a year. The price figure comes from a reverse DCF at a 6.9% discount rate.

Track it and Parra checks each report against the path, and tells you when revenue falls behind it.

Own more than PM? Check up to 5 of your stocks at once, free, no account.

0$20B$40B$60B$43.1B'22'23'24'25Sep '26'26'27'28'29'30What the price needsReportedAnalysts

Both sides

Three stories, three values

Bear

$220

Base

$250

Bull

$283

Today $184

  • Bear $220. Cash flow grows 3% a year for the next 5 years, slower than expected, then slows to long-run growth.
  • Base $250. Cash flow grows 5% a year for the next 5 years, as analysts expect, then slows to long-run growth.
  • Bull $283. Cash flow grows 8% a year for the next 5 years, faster than expected, then slows to long-run growth.

Stories set by rules from the company’s record.

Checkpoints

The revenue the price needs

  1. YearNeedsAnalysts expect
  2. FY2026$43.2B$43.6B, on the path
  3. FY2027$43.2B$45.7B, on the path
  4. FY2028$43.3B$48.7B, on the path
  5. FY2029$43.4B$51.1B, on the path
  6. FY2030$43.5B$53.6B, on the path

Each year's revenue at 0.2% growth from $43.1B in the 12 months to September 2026.

At a glance

Consumer Defensive · Tobacco · listed on NYSE

Revenue, FY2025
$40.6B
Growth, 3 years a year
7.7%
Cash margin
26%
Net debt
$44B
Shares, 3-year change
+0.4%
Dividend yield
3%

What other consumer defensive prices are betting on

Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.